Codexis, Inc.
Ketoreductase polypeptides for the synthesis of chiral compounds
Last updated:
Abstract:
The present disclosure provides engineered ketoreductase enzymes having improved properties as compared to a naturally occurring wild-type ketoreductase enzyme. Also provided are polynucleotides encoding the engineered ketoreductase enzymes, host cells capable of expressing the engineered ketoreductase enzymes, and methods of using the engineered ketoreductase enzymes to synthesize a variety of chiral compounds.
Status:
Grant
Type:
Utility
Filling date:
14 May 2020
Issue date:
1 Feb 2022